Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study

Dan T A Eisenberg, James Mackillop, Meera Modi, Joshua Beauchemin, David Dang, Stephen A Lisman, J Koji Lum, David S Wilson, Dan T A Eisenberg, James Mackillop, Meera Modi, Joshua Beauchemin, David Dang, Stephen A Lisman, J Koji Lum, David S Wilson

Abstract

Background: Research on the genetic basis for impulsivity has revealed an array of ambiguous findings. This may be a result of limitations to self-report assessments of impulsivity. Behavioral measures that assess more narrowly defined aspects of impulsivity may clarify genetic influences. This study examined the relationship between possession of the DRD2 TaqI A and DRD4 48 bp VNTR genetic polymorphisms and performance on a behavioral measure of impulsivity, the delay discounting task (DDT), and three traditional self-report measures.

Methods: 195 individuals (42% male) were recruited from a university campus and were assessed in small group sessions using personal computers. Genotyping was conducted using previously established protocols. For the DRD2 TaqI A locus, individuals were designated as possessing at least one copy of the A1 allele (A1+) or not (A1-), and for the DRD4 48-bp VNTR locus, individuals were designated as having at least one long allele (7 repeats or longer, L+) or not (L-). Principal analyses used multiple univariate factorial 2 (A1+/A1-) x 2 (L+/L-) analyses of variance.

Results: A significant main effect of A1+ status on DDT performance was evident (p = .006) as well as a significant interaction effect (p = .006) between both genes. No other significant effects were evident on the self-report measures, with the exception of a trend toward an interaction effect on the Sensation Seeking Scale. Exploratory analyses suggested that the significant effects were not a function of population stratification or gender.

Discussion: These data suggest that the DRD2 TaqI A and DRD4 VNTR polymorphisms influence impulsivity as measured with a delay discounting task. Specifically, these findings suggest that an interaction between the functional effects of the two unlinked genotypes results in significant difference in the balance of mesolimbic dopaminergic activation relative to frontal-parietal activation. However, these findings are also the first in this area and must be replicated.

Conclusion: These findings suggest a meaningful interaction between the DRD2 TaqI A and DRD4 VNTR polymorphisms in the expression of impulsivity and provide initial support for the utility of using behavioral measures for clarifying genetic influences on impulsivity.

Figures

Figure 1
Figure 1
Main effect of DRD2 TaqI A on delay discounting. Subjective value of $100 from one week to twenty-five years for A1+ and A1- individuals. Squares show the median points of indifference for A1+; diamonds show the median points of indifference for A1- subjects. The hyperbolic curves derived from the median k values of A1+ (continuous line) and A1- groups (dotted line) are given.
Figure 2
Figure 2
DRD2 by DRD4 interaction effect on delay discounting. Subjective value of $100 from one week to twenty-five years for individuals with each allelic combination. Median points of indifference of the four groups are provided with derived hyperbolic curves.

References

    1. Lucentini Gene association studies typically wrong. Scientist. 2004;18:20.
    1. Munafo MR. Candidate gene studies in the 21st century: meta-analysis, mediation, moderation. Genes Brain Behav. 2006;5:3–8. doi: 10.1111/j.1601-183X.2006.00188.x.
    1. Munafo MR, Clark TG, Moore LR, Payne E, Walton R, Flint J. Genetic polymorphisms and personality in healthy adults: A systematic review and meta-analysis. Mol Psychiatry. 2003;8:471–484. doi: 10.1038/sj.mp.4001326.
    1. Gottsman II, Gould TD. The Endophenotype Concept of Psychiatry: Etymology and Strategic Intentions. Am J Psychiatry. 2003;160:636–645. doi: 10.1176/appi.ajp.160.4.636.
    1. Berrettini WH. Genetic bases for endophenotypes in psychiatric disorders. Dialogues Clin Neurosci. 2005;7:95–101.
    1. Freimer N, Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet. 2004;36:1045–1051. doi: 10.1038/ng1433.
    1. Freimer N, Sabatti C. The Human Phenome Project. Nat Genet. 2003;34:15–21. doi: 10.1038/ng0503-15.
    1. Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol Med. 2006:1–18.
    1. Green L, Myerson J. A discounting framework for choice with delayed and probabilistic rewards. Psychol Bull. 2004;130:769–792. doi: 10.1037/0033-2909.130.5.769.
    1. Eysenck SBG, Eysenck HJ. Impulsiveness and Venturesomeness - Their Position in a Dimensional System of Personality Description. Psychol Rep. 1978;43:1247–1255.
    1. Eysenck SBG, Pearson PR, Easting G, Allsopp JF. Age Norms for Impulsiveness, Venturesomeness and Empathy in Adults. Pers Individ Dif. 1985;6:613–619. doi: 10.1016/0191-8869(85)90011-X.
    1. Patton JH, Stanford MS, Barratt ES. Factor Structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995;51:768–774.
    1. Petry NM, Kirby KN, Kranzler HR. Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects. J Stud Alcohol. 2002;63:83–90.
    1. Colder CR, Chassin L. Affectivity and impulsivity: Temperament risk for adolescent alcohol involvement. Psychol Addict Behav. 1997;11:83–97. doi: 10.1037/0893-164X.11.2.83.
    1. Devieux J, Malow R, Stein JA, Jennings TE, Lucenko BA, Averhart C, Kalichman S. Impulsivity and HIV risk among adjudicated alcohol- and other drug-abusing adolescent offenders. Aids Educ Prev. 2002;14:24–35. doi: 10.1521/aeap.14.7.24.23864.
    1. Labouvie EW, McGee CR. Relation of Personality to Alcohol and Drug-Use in Adolescence. J Consult Clin Psychol. 1986;54:289–293. doi: 10.1037/0022-006X.54.3.289.
    1. Nagoshi CT, Wilson JR, Rodriguez LA. Impulsivity, Sensation Seeking, and Behavioral and Emotional Responses to Alcohol. Alcohol Clin Exp Res. 1991;15:661–667. doi: 10.1111/j.1530-0277.1991.tb00575.x.
    1. Grano N, Virtanen M, Vahtera J, Elovainio M, Kivimaki M. Impulsivity as a predictor of smoking and alcohol consumption. Pers Individ Dif. 2004;37:1693–1700. doi: 10.1016/j.paid.2004.03.004.
    1. Geist CR, Herman SM. A comparison of the characteristics of smokers, ex-smokers, and non-smokers. J Clin Psychol. 1990;46:102–105.
    1. MacKillop J, Anderson EJ, Castelda B, Mattson R, Donovick P. Divergent validity of self-report and behavioral assessment measures in pathological gamblers. J Gambl Stud
    1. Steel Z, Blaszczynski A. Impulsivity, personality disorders and pathological gambling severity. Addiction. 1998;93:895–905. doi: 10.1046/j.1360-0443.1998.93689511.x.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental DISORDERS, DSM-IV, 4th edn. Washington, D.C. , American Psychiatric Association; 1994.
    1. Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci. 2005;28:397–+. doi: 10.1017/S0140525X05000075.
    1. Siever LJ, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS. The borderline diagnosis III: Identifying endophenotypes for genetic studies. Biol Psychiatry. 2002;51:964–968. doi: 10.1016/S0006-3223(02)01326-4.
    1. Fossati A, Barratt ES, Carretta I, Leonardi B, Grazioli F, Maffei C. Predicting borderline and antisocial personality disorder features in nonclinical subjects using measures of impulsivity and aggressiveness. Psychiatry Res. 2004;125:161–170. doi: 10.1016/j.psychres.2003.12.001.
    1. Luengo MA, Carrillodelapena MT, Otero JM, Romero E. A Short-Term Longitudinal-Study of Impulsivity and Antisocial-Behavior. J Pers Soc Psychol. 1994;66:542–548. doi: 10.1037/0022-3514.66.3.542.
    1. Petry NM. Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. Psychopharmacology. 2002;162:425–432. doi: 10.1007/s00213-002-1115-1.
    1. Congdon E, Canli T. The Endophenotype of Impulsivity: Reaching Consilience Through Behavioral, Genetic, and Neuroimaging Approaches. Behav Cogn Neurosci Rev. 2005;4:262–281. doi: 10.1177/1534582305285980.
    1. Silverman JM, Pinkham L, Horvath TB, Coccaro EF, Klar H, Schear S, Apter S, Davidson M, Mohs RC, Siever LJ. Affective and Impulsive Personality-Disorder Traits in the Relatives of Patients with Borderline Personality-Disorder. Am J Psychiatry. 1991;148:1378–1385.
    1. Pedersen NL, Plomin R, McClearn GE, Friberg L. Neuroticism, extraversion and related traits in adult twins reared apart and reared together. J Pers Soc Psychol. 1988;55:950–957. doi: 10.1037/0022-3514.55.6.950.
    1. Seroczynski AD, Bergeman CS, Coccaro EF. Etiology of the impulsivity aggression relationship: Genes or environment? Psychiatry Res. 1999;86:41–57. doi: 10.1016/S0165-1781(99)00013-X.
    1. Saudino KJG., J. R. Grant, J. Ibatoulina, A. Marytuina, T. Ravich-Scherbo, I. Whitfield, K. Genetic and Environmental Influences on Personality in Adult Russian Twins. Int J Behav Dev. 1999;23:375–390. doi: 10.1080/016502599383874.
    1. Hur YM, Bouchard TJ. The genetic correlation between impulsivity and sensation seeking traits. Behav Genet. 1997;27:455–463. doi: 10.1023/A:1025674417078.
    1. Fairbanks LA, Newman TK, Bailey JN, Jorgensen MJ, Breidenthal SE, Ophoff RA, Comuzzie AG, Martin LJ, Rogers J. Genetic contributions to social impulsivity and aggressiveness in vervet monkeys. Biol Psychiatry. 2004;55:642–647. doi: 10.1016/j.biopsych.2003.12.005.
    1. Isles AR, Humby T, Walters E, Wilkinson LS. Common genetic effects on variation in impulsivity and activity in mice. J Neurosci. 2004;24:6733–6740. doi: 10.1523/JNEUROSCI.1650-04.2004.
    1. Silverman IW. Gender differences in delay of gratification: A meta-analysis. Sex Roles. 2003;49:451–463. doi: 10.1023/A:1025872421115.
    1. Dom G, D'Haene P, Hulstijn W, Sabbe B. Impulsivity in abstinent early- and late-onset alcoholics: differences in self-report measures and a discounting task. Addiction. 2006;101:50–59. doi: 10.1111/j.1360-0443.2005.01270.x.
    1. Scheres A, Dijkstra M, Ainslie E, Balkan J, Reynolds B, Sonuga-Barke E, Castellanos FX. Temporal and probabilistic discounting of rewards in children and adolescents: Effects of age and ADHD symptoms. Neuropsychologia. 2006;44:2092–2103. doi: 10.1016/j.neuropsychologia.2005.10.012.
    1. Godoy R, Byron E, Reyes-Garcia V, Leonard WR, Patel K, Apaza L, Perez E, Vadez V, Wilkie D. Patience in a foraging-horticultural society: A test of competing hypotheses. J Anthropol Res. 2004;60:179–202.
    1. Harrison GW, Lau MI, Williams MB. Estimating individual discount rates in Denmark: A field experiment. Am Econ Rev. 2002;92:1606–1617. doi: 10.1257/000282802762024674.
    1. Olson SL, Bates JE, Sandy JM, Schilling EM. Early developmental precursors of impulsive and inattentive behavior: from infancy to middle childhood. J Child Psychol Psychiatry. 2002;43:435–447. doi: 10.1111/1469-7610.00035.
    1. Preuss UW, Koller G, Bondy B, Bahlmann M, Soyka M. Impulsive traits and 5-HT2A receptor promoter polymorphism in alcohol dependents: Possible association but no influence of personality disorders. Neuropsychobiology. 2001;43:186–191. doi: 10.1159/000054888.
    1. Patkar AA, Berrettini WH, Hoehe M, Thornton CC, Gottheil E, Hill K, Weinstein SP. Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals. Psychiatry Res. 2002;110:103–115. doi: 10.1016/S0165-1781(02)00098-7.
    1. Baca-Garcia E, Vaquero C, Diaz-Sastre C, Garcia-Resa E, Saiz-Ruiz J, Fernandez-Piqueras J, de Leon J. Lack of association between the serotonin transporter promoter gene polymorphism and impulsivity or aggressive behavior among suicide attempters and healthy volunteers. Psychiatry Res. 2004;126:99–106. doi: 10.1016/j.psychres.2003.10.007.
    1. Retz W, Rosler M, Supprian T, Retz-Junginger P, Thome J. Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm. 2003;110:561–572. doi: 10.1007/s00702-002-0805-5.
    1. Limosin F, Loze JY, Dubertret C, Gouya L, Ades J, Rouillon F, Gorwood P. Impulsiveness as the intermediate link between the dopamine receptor D2 gene and alcohol dependence. Psychiatric Genetics. 2003;13:127–129. doi: 10.1097/00041444-200306000-00013.
    1. Cloninger CR. A Systematic Method for Clinical Description and Classification of Personality Variants - a Proposal. Arch Gen Psychiatry. 1987;44:573–588.
    1. Kluger AN, Siegfried Z, Ebstein RP. A meta-analysis of the association between DRD4 polymorphism and novelty seeking. Mol Psychiatry. 2002;7:712–717. doi: 10.1038/sj.mp.4001082.
    1. Schinka JA, Letsch EA, Crawford FC. DRD4 and novelty seeking: Results of meta-analyses. Am J Med Genet. 2002;114:643–648. doi: 10.1002/ajmg.10649.
    1. Savitz JB, Ramesar RS. Genetic variants implicated in personality: A review of the more promising candidates. Am J Med Genet B Neuropsychiatr Genet. 2004;131B:20–32. doi: 10.1002/ajmg.b.20155.
    1. Nisbett RE, Wilson TD. Telling More Than We Can Know - Verbal Reports on Mental Processes. Psychol Rev. 1977;84:231–259. doi: 10.1037/0033-295X.84.3.231.
    1. Wilson TD, Dunn EW. Self-knowledge: Its limits, value, and potential for improvement. Annu Rev Psychol. 2004;55:493–518. doi: 10.1146/annurev.psych.55.090902.141954.
    1. Evenden JL. Varieties of impulsivity. Psychopharmacology. 1999;146:348–361. doi: 10.1007/PL00005481.
    1. Miller E, Joseph S, Tudway J. Assessing the component structure of four self-report measures of impulsivity. Pers Individ Dif. 2004;37:349–358. doi: 10.1016/j.paid.2003.09.008.
    1. Holt DD, Green L, Myerson J. Is discounting impulsive?. Evidence from temporal and probability discounting in gambling and non-gambling college students. Behav Processes. 2003;64:355–367. doi: 10.1016/S0376-6357(03)00141-4.
    1. Monterosso J, Ehrman R, Napier KL, O'Brien CP, Childress AR. Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction. 2001;96:1825–1837. doi: 10.1046/j.1360-0443.2001.9612182512.x.
    1. Green L, Fristoe N, Myerson J. Temporal discounting and preference reversals in choice between delayed outcomes. Psychon Bull Rev. 1994;1:383–389.
    1. Logan GD. On the ability to inhibit thought and action: a users' guide to the Stop Signal paradigm. In: Dagenbach D, Carr TH, editor. Inhibitory processes in attention, memory, and language. California , Academic Press; 1994. p. Chapter 5.
    1. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science. 2001;292:2499–2501. doi: 10.1126/science.1060818.
    1. Winstanley CA, Theobald DEH, Dalley JW, Cardinal RN, Robbins TW. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex. 2006;16:106–114. doi: 10.1093/cercor/bhi088.
    1. Cardinal RN, Winstanley CA, Robbins TW, Everitt BJ. Limbic corticostriatal systems and delayed reinforcement. (Annals of the New York Academy of Sciences).Adolescent Brain Development: Vulnerabilities and Opportunities. 2004;1021:33–50.
    1. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science. 2004;306:503–507. doi: 10.1126/science.1100907.
    1. Ainslie G. Specious Reward - Behavioral Theory of Impulsiveness and Impulse Control. Psychol Bull. 1975;82:463–496. doi: 10.1037/h0076860.
    1. Petry NM. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology. 2001;154:243–250. doi: 10.1007/s002130000638.
    1. Vuchinich RE, Simpson CA. Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp Clin Psychopharmacol. 1998;6:292–305. doi: 10.1037/1064-1297.6.3.292.
    1. Bickel WK, Odum AL, Madden GJ. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology. 1999;146:447–454. doi: 10.1007/PL00005490.
    1. Mitchell SH. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology. 1999;146:455–464. doi: 10.1007/PL00005491.
    1. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999;128:78–87. doi: 10.1037/0096-3445.128.1.78.
    1. Madden CJ, Petry NM, Badger GJ, Bickel WK. Impulsive and self-control choices in opioid-dependent patients and non-drug using control subjects: drug and monetary rewards. Exp Clin Psychopharmacol. 1997;5:256–263. doi: 10.1037/1064-1297.5.3.256.
    1. Coffey SF, Gudleski GD, Saladin ME, Brady KT. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol. 2003;11:18–25. doi: 10.1037/1064-1297.11.1.18.
    1. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol. 2001;110:482–487. doi: 10.1037/0021-843X.110.3.482.
    1. Ohmura YT., T; Kitamura, N; Wehr, P Three-month stability of delay and probability discounting measures. Exp Clin Psychopharmacol. 2006;14:318–328. doi: 10.1037/1064-1297.14.3.318.
    1. van Gaalen MM, van Koten R, Schoffelmeer ANM, Vanderschuren L. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry. 2006;60:66–73. doi: 10.1016/j.biopsych.2005.06.005.
    1. Richards JB, Sabol KE, de Wit H. Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology. 1999;146:432–439. doi: 10.1007/PL00005488.
    1. Wade TR, de Wit H, Richards JB. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology. 2000;150:90–101. doi: 10.1007/s002130000402.
    1. Zuckerman M. Sensation seeking: Beyond the optimal level of arousal. Hillsdale, NJ , Lawrence Erlbaum Associates; 1979.
    1. Horn NR, Dolan M, Elliott R, Deakin JFW, Woodruff PWR. Response inhibition and impulsivity: an fMRI study. Neuropsychologia. 2003;41:1959–1966. doi: 10.1016/S0028-3932(03)00077-0.
    1. Noble EP. The D-2 dopamine receptor gene: A review of association studies in alcoholism and phenotypes. Alcohol. 1998;16:33–45. doi: 10.1016/S0741-8329(97)00175-4.
    1. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) Hum Mol Genet. 2006;15:2276–2284. doi: 10.1093/hmg/ddl152.
    1. Callier S, Snapyan M, Crom SL, Prou D, Vincent JD, PhilippeVernier Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell. 2003;95:489–502. doi: 10.1016/S0248-4900(03)00089-3.
    1. Hartman DS, Lanau F. Diversity of dopamine receptors: new molecular and pharmacological developments. Pol J Pharmacol. 1997;49:191–199.
    1. Oak JN, Oldenhof J, Van Tol HHM. The dopamine D-4 receptor: one decade of research. Eur J Pharmacol. 2000;405:303–327. doi: 10.1016/S0014-2999(00)00562-8.
    1. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2003;116B:103–125. doi: 10.1002/ajmg.b.10005.
    1. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. . Neuropsychopharmacology. 1996;15:17–29. doi: 10.1016/0893-133X(95)00150-C.
    1. De la Garza R, Madras BK. [H-3]PNU-101958, a D-4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse. 2000;37:232–244. doi: 10.1002/1098-2396(20000901)37:3<232::AID-SYN7>;2-7.
    1. Defagot MC, Antonelli MC. Autoradiographic localization of the putative D4 dopamine receptor in rat brain. Neurochem Res. 1997;22:401–407. doi: 10.1023/A:1027399408608.
    1. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem. 1996;66:915–919.
    1. Ratsma JE, van der Stelt O, Schoffelmeer ANM, Westerveld A, Gunning WB. P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. Alcohol Clin Exp Res. 2001;25:960–967. doi: 10.1111/j.1530-0277.2001.tb02303.x.
    1. Blum K, Braverman E, Holder J, Lubar J, Vincent M, Miller D, Lubar J, Chen T, Comings D. Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors. J Psychoactive Drugs. 2000;Supplement to 32
    1. Thompson J, et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 1997;7
    1. Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P. The 3 ' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res. 2004;67:75–85. doi: 10.1016/S0920-9964(03)00220-2.
    1. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat. 2004;23:540–545. doi: 10.1002/humu.20039.
    1. MacMurray J, Madrid A, Bottini E, Muhleman D, Comings D. Evidence of an emerging collision between the fertility transition and genotype-dependent fertility differentials. In: Kohler JLRHP, editor. Biodemography of Human Reproduction and Fertility. Boston , Kluwer; 2002. pp. 187–200.
    1. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, Flodman P, Spence MA, Schuck S, Swanson JM, Zhang YP, Moyzis RK. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci U S A. 2002;99:309–314. doi: 10.1073/pnas.012464099.
    1. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Vantol HHM. Modulation of Intracellular Cyclic-Amp Levels by Different Human Dopamine D4 Receptor Variants. J Neurochem. 1995;65:1157–1165.
    1. Czermak C, Lehofer M, Liebmann PM, Traynor J. [S-35]GTP gamma S binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine. Eur J Pharmacol. 2006;531:20–24. doi: 10.1016/j.ejphar.2005.11.063.
    1. Schoots O, Van Tol HHM. The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics J. 2003;3:343–348. doi: 10.1038/sj.tpj.6500208.
    1. Van Tol HHM. Multiple dopamine D4 receptor variants in the human population. Nature. 1992;358:149–152. doi: 10.1038/358149a0.
    1. Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HHM. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J Biol Chem. 2005;280:19350–19357. doi: 10.1074/jbc.M414043200.
    1. Asghari V, Schoots O, Vankats S, Ohara K, Jovanovic V, Guan HC, Bunzow JR, Petronis A, Vantol HHM. Dopamine D4 Receptor Repeat - Analysis of Different Native and Mutant Forms of the Human and Rat Genes. Mol Pharmacol. 1994;46:364–373.
    1. Oak JN, Lavine N, Tol HHMV. Dopamine D4 and D2L Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derivied Growth Factor Receptor. Mol Pharmacol. 2001;60:92–103.
    1. Jovanovic V, Guan HC, Van Tol HHM. Comparative pharmacological and functional analysis of the human dopamine D-4.2 and D-4.10 receptor variants. Pharmacogenetics. 1999;9:561–568.
    1. Watts VJ, Vu MN, Wiens BL, Jovanovic V, Tol HHMV, Neve KA. Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology. 1999;141:84–92. doi: 10.1007/s002130050810.
    1. Cho DI, Beorn S, Van Tol HHM, Caron MG, Kim KM. Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D-2 and D-4 receptors. Biochem Biophys Res Commun. 2006;350:634–640. doi: 10.1016/j.bbrc.2006.09.090.
    1. Hamarman S, Fossella J, Ulger C, Brimacombe M, Dermody J. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: A pharmacogenetic study. J Child Adolesc Psychopharmacol. 2004;14:564–574. doi: 10.1089/cap.2004.14.564.
    1. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006;63:808–816. doi: 10.1001/archpsyc.63.7.808.
    1. Hutchison KE, Wooden A, Swift RM, Smolen A, McGeary J, Adler L, Paris L. Olanzapine reduces craving for alcohol: A DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology. 2003;28:1882–1888. doi: 10.1038/sj.npp.1300264.
    1. Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology. 2006;31:1310–1317.
    1. McGough J, McCracken J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigawa S, Moyzis R, Vitiello B. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1314–1322. doi: 10.1097/01.chi.0000235083.40285.08.
    1. Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang XX, Belin TR, Sparkes RS. D-2 and D-4 dopamine receptor polymorphisms and personality. Am J Med Genet. 1998;81:257–267. doi: 10.1002/(SICI)1096-8628(19980508)81:3<257::AID-AJMG10>;2-E.
    1. Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM. The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol. 2002;21:139–146. doi: 10.1037/0278-6133.21.2.139.
    1. Hutchison KE, Stallings M, McGeary J, Bryan A. Population stratification in the candidate gene study: Fatal threat or red herring? Psychol Bull. 2004;130:66–79. doi: 10.1037/0033-2909.130.1.66.
    1. Shields AE, Fortun M, Hammonds EM, King PA, Lerman C, Rapp R, Sullivan PF. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities - A transdisciplinary perspective. Am Psychol. 2005;60:77–103. doi: 10.1037/0003-066X.60.1.77.
    1. GSFL Research Group GSFL Genotyping Protocol - DRD2 (Dopamine Receptor D2) Taq1"A"
    1. Boór K, Rónai Z, Nemoda Z, Gaszner P, Sasvári-Székely M, Guttman A, Kalász. H. Noninvasive Genotyping of Dopamine Receptor D4 (DRD4) Using Nanograms of DNA From Substance-Dependent Patients. Curr Med Chem. 2002;9:793–797. doi: 10.2174/0929867024606821.
    1. DeVona J. Delay Discounting Task. Binghamton ; 2005.
    1. Mazur JE. An adjusting procedure for studying delayed reinforcement. In: Commons ML, Mazur JE, Nevin JA, Rachlin H, editor. Quantitative analyses of behavior, The effect of delay and of intervening events on reinforcement value. Vol. 5. Hillsdale, NJ , Erlbaum; 1987. p. 55–73.
    1. Reynolds B, Schiffbauer R. Measuring state changes in human delay discounting: an experiential discounting task. Behav Process. 2004;67:343–356.
    1. Brzustowski J. Hardy-Weinberg Equilibrium Test
    1. Wacker J, Reuter M, Hennig J, Stemmler G. Sexually dimorphic link between dopamine D2 receptor gene and neuroticism-anxiety. Neuroreport. 2005;16:611–614. doi: 10.1097/00001756-200504250-00019.
    1. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316:1236–1238.
    1. Bland M. An Introduction to Medical Statistics. Third. Oxford University Press; 2000. Multiple significance tests and the Bonferroni correction ; pp. 148–151.
    1. Green L, Myerson J, Ostaszewski P. Discounting of delayed rewards across the life span: age differences in individual discounting functions. Behav Process. 1999;46:89–96. doi: 10.1016/S0376-6357(99)00021-2.
    1. Kruger D., Nesse, R Sexual selection and the Male:Female Mortality Ratio. Evolutionary Psychology. 2004;2:66–77.
    1. Alessi SM, Petry NM. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Process. 2003;64:345–534. doi: 10.1016/S0376-6357(03)00150-5.
    1. Mitchell JM, Fields HL, D’Esposito M, Boettiger CA. Impulsive Responding in Alcoholics. Alcohol Clin Exp Res. 2005;29:2158–2169.
    1. Reynolds B, Richards JB, Wit H. Acute-alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. Pharmacol Biochem Behav. 2006;83:Acute–alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. doi: 10.1016/j.pbb.2006.01.007.
    1. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J. 2004;4:102–109. doi: 10.1038/sj.tpj.6500227.
    1. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. Mol Psychiatry. 2005;10:407–414. doi: 10.1038/sj.mp.4001588.
    1. Miller WB, Pasta DJ, MacMurray J, Chiu C, Wu H, Comings DE. Dopamine receptor genes are associated with age at first sexual intercourse. J Biosoc Sci. 1999;31:43–54. doi: 10.1017/S0021932099000437.
    1. Carrasco X, Rothhammer P, Moraga M, Henriquez H, Chakraborty R, Aboitiz F, Rothhammer F. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:51–54. doi: 10.1002/ajmg.b.30259.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅